Cancer, Viruses, and Mass Migration: Paul Berg’s Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967–1980
Author:
- 2 February 2008
- journal article
- other
- Published by Springer Nature in Journal of the History of Biology
- Vol. 41 (4) , 589-636
Abstract
The existing literature on the development of recombinant DNA technology and genetic engineering tends to focus on Stanley Cohen and Herbert Boyer’s recombinant DNA cloning technology and its commercialization starting in the mid-1970s. Historians of science, however, have pointedly noted that experimental procedures for making recombinant DNA molecules were initially developed by Stanford biochemist Paul Berg and his colleagues, Peter Lobban and A. Dale Kaiser in the early 1970s. This paper, recognizing the uneasy disjuncture between scientific authorship and legal invention in the history of recombinant DNA technology, investigates the development of recombinant DNA technology in its full scientific context. I do so by focusing on Stanford biochemist Berg’s research on the genetic regulation of higher organisms. As I hope to demonstrate, Berg’s new venture reflected a mass migration of biomedical researchers as they shifted from studying prokaryotic organisms like bacteria to studying eukaryotic organisms like mammalian and human cells. It was out of this boundary crossing from prokaryotic to eukaryotic systems through virus model systems that recombinant DNA technology and other significant new research techniques and agendas emerged. Indeed, in their attempt to reconstitute ‹life’ as a research technology, Stanford biochemists’ recombinant DNA research recast genes as a sequence that could be rewritten thorough biochemical operations. The last part of this paper shifts focus from recombinant DNA technology’s academic origins to its transformation into a genetic engineering technology by examining the wide range of experimental hybridizations which occurred as techniques and knowledge circulated between Stanford biochemists and the Bay Area’s experimentalists. Situating their interchange in a dense research network based at Stanford’s biochemistry department, this paper helps to revise the canonized history of genetic engineering’s origins that emerged during the patenting of Cohen–Boyer’s recombinant DNA cloning procedures.Keywords
This publication has 74 references indexed in Scilit:
- Book ReviewsThe Oral History Review, 1999
- Some genes were isolated and their structure studied before the recombinant DNA eraBioEssays, 1994
- Renato Dulbecco and the new animal virology: Medicine, methods, and moleculesJournal of the History of Biology, 1993
- Bacteriophage lambda as a model systemBioEssays, 1986
- The Manipulation of GenesScientific American, 1975
- A system for mapping DNA sequences in the chromosomes of Drosophila melanogasterCell, 1974
- Calcium-dependent bacteriophage DNA infectionJournal of Molecular Biology, 1970
- Induction of virus multiplication in 3T3 cells transformed by a thermosensitive mutant of polyoma virus: II. Formation of oligomeric polyoma DNA moleculesJournal of Molecular Biology, 1970
- On the structure of the ends of lambda DNAJournal of Molecular Biology, 1965
- Transformation of Cells in vitro by VirusesScience, 1963